ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.898,24
0,01%
Brent Oil
82,765
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) Notícias

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BNTC
DataHoraFonteTítuloCódigoCompanhia
08/03/202418:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
08/03/202418:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
06/03/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
26/02/202411:06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
23/02/202418:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
13/02/202410:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
17/11/202310:00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
13/11/202310:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
20/10/202317:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
20/10/202307:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
21/09/202309:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
21/09/202309:00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
11/08/202314:00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
10/08/202317:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
08/08/202323:30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
07/08/202309:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
25/07/202314:00GlobeNewswire Inc.Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023NASDAQ:BNTCBenitec Biopharma Limited
07/07/202317:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
26/06/202309:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BNTCBenitec Biopharma Limited
26/06/202309:00GlobeNewswire Inc.Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNASDAQ:BNTCBenitec Biopharma Limited
15/06/202317:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202309:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202309:00GlobeNewswire Inc.Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
08/05/202309:05GlobeNewswire Inc.Benitec Biopharma to Present at the OPMD International ConferenceNASDAQ:BNTCBenitec Biopharma Limited
08/05/202309:00GlobeNewswire Inc.Benitec Biopharma to Present at the JMP Securities Life Sciences ConferenceNASDAQ:BNTCBenitec Biopharma Limited
18/04/202317:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BNTCBenitec Biopharma Limited
13/02/202310:00GlobeNewswire Inc.Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
23/01/202311:48GlobeNewswire Inc.Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development ProgramNASDAQ:BNTCBenitec Biopharma Limited
13/12/202208:04Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BNTCBenitec Biopharma Limited
10/11/202210:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
 Apresentando as notícias mais relevantes sobre:NASDAQ:BNTC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
BOV
PRIO3
PETRORIO ON
BOV
HETA4
HERCULES PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados